Biogen (BIIB) Stock Price & AI Analysis

NASDAQ USA
$231.69
-$2.15 (-0.92%)

Biogen | Analysts Recommandations

No Ratings

Biogen | Latest news

Market Data

Performance

Technical Indicators

Company Profile

Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.